FindTrial
Sign In

a-fetoprotein and regular inspection for detection of early hepatocellular carcinoma

Clinical study of patients with hepatocellular carcinoma complicated by gastroesophageal varices in liver cirrhosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100045099
Enrollment
Unknown
Registered
2021-04-06
Start date
2021-04-06
Completion date
Unknown
Last updated
2021-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cirrhosis, hepatocellular carcinoma

Interventions

AFP>=20ng/mL:Nil
AFP<20ng/mL:Nil

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Patients aged > 18 years; 2.Patients did not have HCC; 3.Histologically confirmed carcinoma, regardless of the time of biopsy; 4.The opportunity to participate in regular visits; 5.Patients had no co-diseases associated with a life expectancy <1 year.

Exclusion criteria

Exclusion criteria: Failure to complete regular follow-up.

Design outcomes

Primary

MeasureTime frame
Serum a-fetoprotein;Magnetic resonance imaging;Computerized tomography;—

Countries

China

Contacts

Public ContactKong Derun

The First Affiliated Hospital of Anhui Medical University

kongderun168@163.com+86 13955155476

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026